1. |
The International Diabetes Federation (IDF). IDF diabetes atlas 9th edition 2019. Brussels, Belgium: 2019. (2019-11-14)[2021-10-08].https://www.diabetesatlas.org./en/resources/.
|
2. |
中华糖尿病杂志指南与共识编写委员会. 中国糖尿病药物注射技术指南(2016 年版). 中华糖尿病杂志, 2017, 9(2): 79-105.
|
3. |
Thow JC, Johnson AB, Marsden S, et al. Morphology of palpably abnormal injection sites and effects on absorption of isophane (NPH) insulin. Diabet Med, 1990, 7(9): 795-799.
|
4. |
Richardson T, Kerr D. Skin-related complications of insulin therapy: epidemiology and emerging management strategies. Am J Clin Dermatol, 2003, 4(10): 661-667.
|
5. |
Pickup JC, Yemane N, Brackenridge A, et al. Nonmetabolic complications of continuous subcutaneous insulin infusion: a patient survey. Diabetes Technol Ther, 2014, 16(3): 145-149.
|
6. |
Rostom A, Dube C, Cranney A, et al. Celiac Disease Rockville (MD): Agency for Healthcare Research and Quality (US), (Evidence Reports/Technology Assessments, No. 104. ) Appendix D. Quality Assessment Forms. (2004-09-10)[2021-10-08].https://www.ncbi.nlm.nih.gov/books/NBK35156/.
|
7. |
曾宪涛, 刘慧, 陈曦, 等. Meta 分析系列之四: 观察性研究的质量评价工具. 中国循证心血管医学杂志, 2012, 4(4): 297-299.
|
8. |
Aljaber AN, Sales I, Almigbal TH, et al. The prevalence of lipohypertrophy and its associated factors among Saudi patients with type 2 diabetes mellitus. J Taibah Univ Med Sci, 2020, 15(3): 224-231.
|
9. |
Arora S, Agrawal NK, Shanthaiah DM, et al. Early detection of cutaneous complications of insulin therapy in type 1 and type 2 diabetes mellitus. Prim Care Diabetes, 2021, 15(5): 859-864.
|
10. |
Blanco M, Hernández MT, Strauss KW, et al. Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes. Diabetes Metab, 2013, 39(5): 445-453.
|
11. |
Coninck De C, Frid A, Gaspar R, et al. Results and analysis of the 2008-2009 Insulin Injection Technique Questionnaire survey. J Diabetes, 2010, 2(3): 168-179.
|
12. |
Frid AH, Hirsch LJ, Menchior AR, et al. Worldwide injection technique questionnaire study: injecting complications and the role of the professional. Mayo Clin Proc, 2016, 91(9): 1224-1230.
|
13. |
Gentile S, Strollo F, Satta E, et al. Insulin-related lipohypertrophy in hemodialyzed diabetic people: a multicenter observational study and a methodological approach. Diabetes Ther, 2019, 10(4): 1423-1433.
|
14. |
Gupta SS, Gupta KS, Gathe SS, et al. Clinical Implications of lipohypertrophy among people with type 1 diabetes in India. Diabetes Technol Ther, 2018, 20(7): 483-491.
|
15. |
Ji L, Sun Z, Li Q, et al. Lipohypertrophy in China: prevalence, risk factors, insulin consumption, and clinical impact. Diabetes Technol Ther, 2017, 19(1): 61-67.
|
16. |
Luo D, Shi Y, Zhu M, et al. Subclinical lipohypertrophy: easily ignored complications of insulin therapy. J Diabetes Complications, 2021, 35(3): 107806.
|
17. |
Pozzuoli GM, Laudato M, Barone M, et al. Errors in insulin treatment management and risk of lipohypertrophy. Acta Diabetol, 2018, 55(1): 67-73.
|
18. |
Baruah MP, Kalra S, Bose S, et al. An audit of insulin usage and insulin injection practices in a large Indian cohort. Indian J Endocr Metab, 2017, 21: 443-452.
|
19. |
Vardar B, Kizilci S. Incidence of lipohypertrophy in diabetic patients and a study of influencing factors. Diabetes Res Clin Pract, 2007, 77(2): 231-236.
|
20. |
Pahuja V, Punjot P, Fernandes G, et al. Exploring the factors associated with lipohypertrophy in insulin-treated type 2 diabetes patients in a tertiary care hospital in Mumbai, India. Int J Diabetes Develop Countr, 2019, 39(3): 426-431.
|
21. |
Gentile S, Guarino G, Corte TD, et al. Insulin-induced skin lipohypertrophy in type 2 diabetes: a multicenter regional survey in southern Italy. Diabetes Ther, 2020, 11(9): 2001-2017.
|
22. |
Gentile S, Guarino G, Della Corte T, et al. Bruising: a neglected, though patient-relevant complication of insulin injections coming to light from a real-life nationwide survey. Diabetes Ther, 2021, 12(4): 1143-1157.
|
23. |
Song Z, Guo X, Ji L, et al. Insulin injection technique in china compared with the rest of the world. Diabetes Ther, 2018, 9(6): 2357-2368.
|
24. |
Hacene MNB, Saker M, Youcef A, et al. Insulin injection technique in the western region of Algeria, Tlemcen. Pan Afr Med J, 2020, 36: 327-340.
|
25. |
李幼平, 杨克虎. 循证医学. 北京: 人民卫生出版社, 2014: 145-146.
|
26. |
Conwell LS, Pope E, Artiles AM, et al. Dermatological complications of continuous subcutaneous insulin infusion in children and adolescents. J Pediatr, 2008, 152(5): 622-628.
|
27. |
Gentile S, Guarino G, Giancaterini A, et al. A suitable palpation technique allows to identify skin lipohypertrophic lesions in insulin-treated people with diabetes. Springer Plus, 2016, 5: 563.
|